Anders Vik

Author information from the last article

Seksjon for blodsykdommer

Universitetssykehuset i Nord-Norge

Institutt for klinisk medisin

Universitetet i Tromsø

Forfatterbidrag: utforming, datainnsamling, tolking av data, litteratursøk, revisjon av manuset og godkjenning av innsendte manusversjon.

Anders Vik er ph.d., spesialist i indremedisin og i blodsykdommer, førsteamanuensis og overlege.

Articles by Anders Vik

High-dose melphalan and autologous haematopoietic stem cell transplantation in multiple myeloma in Norway, 2008–2020

Jakob Nordberg Nørgaard,
Kari Lenita Falck Moore,
Tobias S. Slørdahl,
Anders Vik,
Tor Henrik Anderson Tvedt,
Hedda Berg Monsen,
Fredrik Schjesvold

13.04.2026: High-dose melphalan and autologous haematopoietic stem-cell transplantation (ASCT) has been used to treat multiple myeloma in Norway since the 1990s (1). In this treatment, the patient receives high-dose chemotherapy with melphalan, followed by reinfusion of the patient's previously harvested stem...

Equal access to high-quality care across all regional health authorities

Anders Vik

08.10.2025: More patients than ever are undergoing allogeneic stem cell transplantation as a treatment for acute myeloid leukaemia. Access to this intervention is consistent throughout Norway. In a study published in this edition of the Journal of the Norwegian Medical Association, Busterud et al. examine the...

A pregnant woman with pancytopenia

Hilde Jensvoll,
Marie Falkenberg Smeland,
Heidi Tiller,
Øystein Lunde Holla,
Trine E. Prescott,
Anders Vik

18.11.2019: A primigravida was found to have anaemia, leukopenia and thrombocytopenia. A broad exploratory assessment yielded no diagnostic explanation. In the course of her pregnancy she required frequent transfusions of erythrocytes and platelets, up to three times a week. The final diagnosis was not made...